Health Care·Pharmaceuticals·$3.0B
The AI-assisted earnings brief for NKTR Q4-2023 is being prepared. Check back shortly.
COMPANIA DE MINAS BU ADR
Mar 1, 2024
AMNEAL PHARMACEUTICA Class A
SEA LTD Class A ADR
Mar 4, 2024
AEROVIRONMENT INC
CRESCENT ENERGY CO A